Development of a comorbidity index using physician claims data.
about
Defining comorbidity: implications for understanding health and health servicesOutcomes of localized prostate cancer following conservative managementInfluence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapyCombining COPD with clinical, pathological and demographic information refines prognosis and treatment response prediction of non-small cell lung cancerConducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CMOutcomes following local therapy for early-stage breast cancer in non-trial populationsPatterns of cancer screening, incidence and treatment disparities in China: protocol for a population-based studyReadmission predicts 90-day mortality after esophagectomy: Analysis of Surveillance, Epidemiology, and End Results Registry linked to Medicare outcomes.Readmission after lung cancer resection is associated with a 6-fold increase in 90-day postoperative mortality.Postoperative mortality is an inadequate quality indicator for lung cancer resection.Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis.Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer.Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancerIntensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.Determining compound comorbidities for heart failure from hospital discharge data.Surgeon influence on use of needle biopsy in patients with breast cancer: a national medicare study.Overall survival advantage with partial nephrectomy: a bias of observational data?Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.Predicting life expectancy for community-dwelling older adults from Medicare claims data.Cisplatin versus carboplatin-based regimens for the treatment of patients with metastatic lung cancer. An analysis of Veterans Health Administration data.Postoperative 30-day mortality in patients undergoing surgery for colorectal cancer: development of a prognostic model using administrative claims data.Adding flexible temporal constraints to identify chronic comorbid conditions in ambulatory claims dataControlling confounding of treatment effects in administrative data in the presence of time-varying baseline confounders.Hospital Characteristics Associated with Stage II/III Rectal Cancer Guideline Concordant Care: Analysis of Surveillance, Epidemiology and End Results-Medicare Data.In search of the perfect comorbidity measure for use with administrative claims data: does it exist?Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations.Provider continuity prior to the diagnosis of advanced lung cancer and end-of-life care.Minimally Invasive Staging Surgery in Women with Early-Stage Endometrial Cancer: Analysis of the National Cancer Data Base.Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data.Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidityGonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancerVariation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicityFrequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.Ability of Medicare claims data to identify nursing home patients: a validation study.Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare dataThirty-day hospital readmissions in systemic lupus erythematosus: predictors and hospital- and state-level variationRate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US.Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis.Development and validation of an index of musculoskeletal functional limitations.
P2860
Q24647220-7F95AE6D-5C4F-46AF-AE1C-78B4FC127F82Q24647380-5D06B52C-8D15-4B15-A89B-D667ED8B4D24Q27308917-DF8E8BA9-615E-491C-8DD2-C0F9B50FF0F5Q28388778-127B5187-F42D-43E0-85AC-E4BE2D103FA1Q28397435-FE51099B-3F60-4773-81C5-B2B155B2587FQ28749604-907B2089-9777-4C07-B498-E4ADC5118F68Q30276194-984DFAD5-5774-4409-AEA6-DB9EABF70144Q30278612-62C743EF-6F01-47F1-B665-B08F6E4ED21BQ30370176-046A390E-E586-428D-BE07-3D81F09F90A4Q30407624-0A1EDEA8-2260-49C8-9C98-F433BA58A837Q30418160-6E39F8F5-7EF3-40F9-B757-4B8518DB38A5Q30422095-B5035E93-1991-484F-B42A-44B7F0801C46Q30422372-763083D3-7D76-4256-B4DC-B4B163EBB0BCQ30422446-80C142CF-5260-4F12-8BF4-6D9CE079EEDEQ30557710-5F5F46FA-85C7-41F4-BEDE-286D59A082D6Q30585464-FC64094B-9D20-430B-8939-0D3E89B033D8Q30587015-11D2AC73-72F1-48FB-9450-5696199429B1Q30626270-8D09B3AF-4689-4811-B9CF-A44BA80CCAE0Q30640824-8EB06E44-81A5-4E0C-BE95-D719ED280BB2Q30655164-91432A6D-38CA-4B73-A91B-CEF5AA8362DBQ30784508-E656E258-6B71-41E2-A180-A601FAD871A8Q30841395-7F82CD95-3B24-481F-96CB-35726EC76887Q30946984-8D58CF4C-763F-4ACB-9E96-239411BD07F9Q31028268-8C9B8781-E399-4E47-8E02-4D86F3A64B97Q31031704-8B76525C-4A97-4ED2-A053-FA317889A387Q31049563-72983A3C-7E07-4BB1-A153-CBDD1FB84186Q31119855-C92419F8-8ED8-44F5-9527-EBB51119F813Q31138079-B94E663F-9A4A-4108-93B0-42EC66521F07Q31154128-317094DD-4A2E-43AD-9B39-3742A5E8855BQ31155248-76A7B222-4AB8-41EE-82FA-8B28F05DB72DQ33302869-EF357233-DE8B-4580-9C40-094D1B175005Q33351115-8AAF0D27-775C-4CB5-87E6-17B65F94A075Q33367028-783CD5E7-D32F-4B41-9438-854AB6670E40Q33372268-0636153B-A591-4D8D-87E2-65ECB688D392Q33379591-76D2EFCF-6044-406E-A6B1-B2B1AB660262Q33400824-989D8668-2F56-4BAD-AC75-B64DECE1925AQ33416972-EC043C71-6172-439F-84F1-24106FE9063CQ33433662-8053D5A9-6137-4179-8A7C-6CD8E81EBEE8Q33434251-6BB803D9-79C8-4185-B604-B5E99E6B8A89Q33461905-0044A63B-470A-41AD-9C6D-90D304109308
P2860
Development of a comorbidity index using physician claims data.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Development of a comorbidity index using physician claims data.
@ast
Development of a comorbidity index using physician claims data.
@en
type
label
Development of a comorbidity index using physician claims data.
@ast
Development of a comorbidity index using physician claims data.
@en
prefLabel
Development of a comorbidity index using physician claims data.
@ast
Development of a comorbidity index using physician claims data.
@en
P2093
P1476
Development of a comorbidity index using physician claims data.
@en
P2093
Klabunde CN
Potosky AL
P304
P356
10.1016/S0895-4356(00)00256-0
P577
2000-12-01T00:00:00Z